Autoclaves are closed chambers used for sterilizing surgical equipment and other surgical instruments. Steam sterilization is a non-toxic and inexpensive way to eliminate microbes and spores. Steam sterilization is based on four parameters, which are steam, pressure, temperature, and time of exposure. The autoclave is generally used in laboratory for media preparation, pharmaceutical products, and regulated medical waste. Steam autoclaves works on two basic principles, based on which they are of two types – gravity displacement autoclave and high-speed prevacuum sterilizer. The global steam autoclave is majorly driven by increasing prevalence of hospital-acquired infectious diseases, technological advancement, and increasing number of hospital facilities, laboratories, etc.
Steam Autoclave Market – Drivers
New product launches with advanced technology is expected to drive the steam autoclave market growth during the forecast period. For instance, in 2016, Astella Scientific launched a touch screen based controller for its autoclave ranges, combined with analogue and digital input/output modules. Controller software has features to improve speed and management of load cycles with menu system, cycle selection, customizable access levels, and password protection. Moreover, it stores historic data up to 5,000 cycles and can be viewed or downloaded via USB port. Manufacturers are also focusing on introducing high capacity steam autoclave at low prices, to sustain in the growing autoclave market.
Increasing prevalence of hospital-acquired infectious (HAIs) is expected to propel growth of the steam autoclave market. For instance, according to World Health Organization (WHO) factsheet, in developed countries 7 out of 100 hospitalized patients acquire one of the other healthcare associated infection, whereas, in emerging countries the ratio is 10 out of 100. Moreover, according to Center for Disease Control and Prevention’s (CDC) annual National and State Healthcare-Associated Infections Progress Report (HAI Progress Report, 2014), the burden of HAIs in the U.S. hospitals was reported to be 722,000 in acute care hospitals in 2011. Moreover, nosocomial infection including central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections, surgical site infections, and ventilator-associated pneumonia are some of the common hospital acquired infections. These are expected to be major factors leading to increasing demand for sterilization of surgical instruments, medical waste management, and other consumables.
Moreover, increasing number of surgical procedures and increasing preference for minimally invasive surgical procedures is also expected to fuel growth of the steam autoclave market. According to a study presented by the Centers of Disease Control & Prevention (CDC) 2014, around 4.7 million people underwent total knee arthroplasty, while 2.5 million underwent total hip arthroplasty in the U.S. Rapidly increasing surgical waste and hazardous bio-medical waste is also expected to fuel the steam autoclave market growth. For instance, according to BioMedical Waste Solutions, LLC., hospitals in the U.S. produce over 5.9 million tons of waste, annually. Same source stated that hospital produce 33 lbs. of medical waste per day per staffed bed. Furthermore, governments of various countries are focusing on investing in proper disposal of medical waste and this is also expected to support growth of the steam autoclave market. For instance, in 2012, the U.S. government invested around US$ 2.5 billion for proper disposal of medical waste. Moreover, in 2015, the Government of Liberia, with the support of United Nations Development Programme, installed equipment to sterilize and manage medical waste in the hospitals of the country. Under this initiative, the government installed autoclaves valued at US$ 35,000 at various hospitals.
Steam Autoclave Market – Restraint
Growth of the steam autoclave market is expected to be hindered by increasing use of disposable products by healthcare settings and high cost of large capacity autoclaves used in pharmaceutical industries and research laboratories.
Steam Autoclave Market - Regional Analysis
Regional segmentation of steam autoclave market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is estimated to hold the dominant position in the global steam autoclave market followed by Europe, owing to high incidence of hospital acquired diseases. According to article published in Elsevier journal in year 2017, although there is a decrease in central line-associated bloodstream infections from 2008 to 2013 in the U.S. hospitals, an estimated 30,100 central line-associated bloodstream infections still occur in ICU and acute facilities wards in the U.S. each year. Furthermore, stringent sterilization and disinfection guidelines for medical waste disposal by regulatory bodies will increase number of autoclave installations by waste management agencies in turn aiding in growth of the market in these regions. Asia Pacific is expected to be the fastest growing region in the global steam autoclaves market over the forecast period due to increasing surgery procedures coupled with medical tourism. The lower cost of surgeries in countries like India and China attracts patients in turn enhancing surgery procedures in these region.
Steam Autoclave Market – Competitive Landscape
Key players operating in the global steam autoclave market are Steelco S.P.A., Dental X spa, Tuttnauer Co. Ltd., BMM Weston Holdings Ltd., Getinge Infection Control AB, BMT Medical Technology s.r.o., Belimed AG, ERYIGIT A.S., and Hanshin Medical Co., Ltd. Mergers and acquisition are the key strategies employed by market players, to maintain their position in the competitive market. For instance, in 2017, Bondtech Corp., an autoclave manufacturer, and World Autoclave Solutions announced their merger, to bring an autoclave solution of any size for all industrial applications at an affordable price.
Steam Autoclave Market Taxonomy
By Configuration
By End User
By Region
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients